Stay informed about the opinions, scientific advice, and ongoing safety evaluations of cosmetic ingredients issued by the Scientific Committee on Consumer Safety (SCCS), which may lead to upcoming regulations or amendments.
On average, 70% of our news is listed, while updates from the last 30 days are not visible.
To get access to all content and services,
Start your Free Trial or Discover our plans.
Already a Premium member? Sign In
On 29 April 2022, the SCCS meeting of the Working Group (WG) on nanomaterials in cosmetic products was held.
On 19-20 April 2022, the SCCS meeting of the Working Group (WG) on cosmetic ingredients in cosmetic products was held.
Considering the concerns related to potential endocrine-disrupting properties of “Salicylic Acid” the European Commission has asked the Scientific Committee to assess its safety in cosmetic products. On 3 February 2022, this mandate has been accepted by the SCCS and the Committee has nine months to deliver its Opinion.
Based on the SCCS Opinion “SCCS/1613/19” (and its addendum “SCCS/1626/20”) on the safety of aluminium in cosmetic products (including deodorants and antiperspirants, toothpaste, and lipsticks), the European Commission asked the Scientific Committee to assess other types of products, considering also the aggregate exposure to this substance.
The Scientific Committee has published its final Opinion on prostaglandins and their analogues. It was adopted by written procedure on 3 February 2022.
The Scientific Committee has published the preliminary opinion on alpha-arbutin and beta-arbutin after the mandate given by the European Commission to assess their potential to release hydroquinone (HQ). Hydroquinone (CAS No. 123-31-9, EC No. 204-617-8) is prohibited as a cosmetic ingredient. The SCCS adopted this document at its plenary meeting Read more…
The Scientific Committee has published the preliminary scientific advice on Triclocarban and Triclosan as substances with potential endocrine-disrupting properties in cosmetic products. The SCCS adopted this scientific advice at its plenary meeting on 15-16 March 2022.
The SCCS published the preliminary version of its revision of the scientific opinion on Vitamin A (retinol, retinyl palmitate, and retinyl acetate). The deadline for comments was set for 7 February 2022.
Considering the concerns related to potential endocrine disrupting properties of “Butylparaben”, the European Commission has asked the Scientific Committee to assess its safety as a preservative in cosmetic products. On 5 October 2021, this mandate has been accepted by the SCCS and the Committee has nine months to deliver its Read more…
The European Commission has asked the SCCS to assess the safety of Hydroxyapatite (nano). On 15-16 March 2022, the SCCS accepted this mandate and the Committee has six months to deliver its Opinion.